Effects of polymorphisms in nucleotide-binding oligomerization domains 1 and 2 on biomarkers of the metabolic syndrome and type II diabetes
- PMID: 22367890
- PMCID: PMC3380195
- DOI: 10.1007/s12263-012-0287-5
Effects of polymorphisms in nucleotide-binding oligomerization domains 1 and 2 on biomarkers of the metabolic syndrome and type II diabetes
Abstract
The innate immune receptor toll-like receptor 4 (TLR4) has been implicated in mediating some of the effects of dietary lipids on inflammation and type 2 diabetes (T2D). Similar to TLR4, the nucleotide-binding oligomerization domains (Nods) 1 and 2 are also proteins of innate immunity, which can respond to lipids and initiate pro-inflammatory signalling that plays a role in the aetiology of T2D. The objective was to determine the effect of Nod1 (Glu266Lys) and Nod2 (Ser268Pro) genotypes on factors associated with the metabolic syndrome (MetS), and whether they modify the association between dietary lipids and biomarkers of the MetS. Men and women (n = 998) between the ages of 20-29 years were genotyped for both polymorphisms, completed a one-month, semiquantitative food frequency questionnaire and provided a fasting blood sample. The Glu266Lys polymorphism in Nod1 was not associated with any of the biomarkers of the MetS, but modified the association between dietary saturated fat (SFA) and insulin sensitivity, as measured by HOMA-IR (p for interaction = 0.04). Individuals with the Glu/Glu or Glu/Lys genotype showed no significant relationship between dietary SFA and HOMA-IR (β = -0.002 ± 0.006, p = 0.77; and β = -0.003 ± 0.006, p = 0.61), while those with the Lys/Lys genotype showed a positive association (β = 0.033 ± 0.02, p = 0.03). The Nod2 Ser268Pro polymorphism was not associated with components of the MetS and did not modify the relationship between dietary lipid intake and the biomarkers of MetS. In summary, the Nod1 Glu266Lys polymorphism modifies the relationship between dietary SFA intake and HOMA-IR, suggesting that Nod1 may act as an intracellular lipid sensor affecting insulin sensitivity.
Figures
Similar articles
-
Polymorphisms in Toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol.Metabolism. 2011 Aug;60(8):1131-5. doi: 10.1016/j.metabol.2010.12.006. Epub 2011 Feb 8. Metabolism. 2011. PMID: 21306745
-
Increased NOD1, but not NOD2, activity in subcutaneous adipose tissue from patients with metabolic syndrome.Obesity (Silver Spring). 2015 Jul;23(7):1394-400. doi: 10.1002/oby.21113. Epub 2015 Jun 5. Obesity (Silver Spring). 2015. PMID: 26052894
-
Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.Arch Oral Biol. 2011 Oct;56(10):1064-72. doi: 10.1016/j.archoralbio.2011.02.020. Epub 2011 Mar 31. Arch Oral Biol. 2011. PMID: 21457942
-
Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases.Biosci Rep. 2012 Dec;32(6):597-608. doi: 10.1042/BSR20120055. Biosci Rep. 2012. PMID: 22908883 Free PMC article. Review.
-
Contribution of Nucleotide-Binding Oligomerization Domain-like (NOD) Receptors to the Immune and Metabolic Health.Biomedicines. 2024 Feb 1;12(2):341. doi: 10.3390/biomedicines12020341. Biomedicines. 2024. PMID: 38397943 Free PMC article. Review.
Cited by
-
Mediators of Metabolism: An Unconventional Role for NOD1 and NOD2.Int J Mol Sci. 2021 Jan 25;22(3):1156. doi: 10.3390/ijms22031156. Int J Mol Sci. 2021. PMID: 33503814 Free PMC article. Review.
-
A novel risk score model based on pyroptosis-related genes for predicting survival and immunogenic landscape in hepatocellular carcinoma.Aging (Albany NY). 2023 Feb 24;15(5):1412-1444. doi: 10.18632/aging.204544. Epub 2023 Feb 24. Aging (Albany NY). 2023. PMID: 36920176 Free PMC article.
-
NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet.Sci Rep. 2020 Jul 23;10(1):12317. doi: 10.1038/s41598-020-69295-2. Sci Rep. 2020. PMID: 32704052 Free PMC article.
-
Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.Pediatr Diabetes. 2018 Aug;19(5):945-954. doi: 10.1111/pedi.12660. Epub 2018 May 7. Pediatr Diabetes. 2018. PMID: 29473705 Free PMC article. Clinical Trial.
-
Single nucleotide polymorphisms and haplotypes associated with feed efficiency in beef cattle.BMC Genet. 2013 Sep 25;14:94. doi: 10.1186/1471-2156-14-94. BMC Genet. 2013. PMID: 24066663 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources